AARXION ANDA HLDING
SpecialtyAARXION ANDA HLDING is a specialty pharmaceutical company focused on Immunology, Gastroenterology.
AARXION ANDA HLDING's Key Drugs
AARXION ANDA HLDING's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
AARXION ANDA HLDING's Recent FDA Approvals
New NDA/BLA approvals for AARXION ANDA HLDING over the last two years — novel drugs only, excluding generics and label supplements.
AARXION ANDA HLDING's Therapeutic Areas
AARXION ANDA HLDING's approved drugs and pipeline span 2 therapeutic areas, led by Immunology and Gastroenterology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
AARXION ANDA HLDING's Top Competitors
AARXION ANDA HLDING's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Bristol-Myers Squibb, and BAUSCH. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
AARXION ANDA HLDING Pipeline Snapshot
Active clinical trials for AARXION ANDA HLDING across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Immunology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1981-04-06
- Latest
- 2023-11-07
- Applications
- 4